Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The Conference Forum Announces the Launch of the 2nd Annual Medicaid Rebate Summit

Published: Wednesday, October 30, 2013
Last Updated: Wednesday, October 30, 2013
Bookmark and Share
Summit will address the interpretation of the anticipated Final Rule and the larger implications of Medicaid expansion.

In anticipation of the Final Rule and Medicaid expansion, the Conference Forum announced the launch of the 2nd annual Medicaid Rebate Summit for January 22-23 in Washington DC. The MRS Summit helps pharmaceutical, biotech and generic drug manufacturers along with states and pharmacy leaders to navigate the complexities of the Medicaid Rebate process.

Co-Chair, Jim Abrams, Director, Government Pricing & Reporting, Mylan Pharmaceuticals, noted "The Summit's agenda is timely and includes topics that will benefit all Government Pricing staffers and Pharma professionals who are impacted by developments in government pricing programs."

Program Co-Chair, Stephanie Kupski, Sr. Director Managed Markets & HCP Compliance, Iroko Pharmaceuticals LLC, added, "With the GP community eagerly awaiting the release of the final AMP rule in January, the Medicaid Rebate Summit couldn’t be more relevant. I look forward to discussing implementation strategies with my colleagues.”

“The need to bring together CMS, manufacturers, states, pharmacy leaders and other key stakeholders to work through the many changes affecting the MDRP is so crucial that we moved the event up a month to January,” explains Valerie Bowling, Executive Director of the Conference Forum.

The 2014 Keynote is Adam J. Fein, PhD, President, Pembroke Consulting and Author, Drug Channels. Dr Fein was chosen as the 2014 Keynote for being the most recommended speaker by manufacturers for his insights into pharmaceutical economics and the impact on Medicaid Drug Rebates. 2013 Keynote, Alice Valder Curran of Hogan Lovells is back to help demystify the interpretation of the Final Rule.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Conference Forum Announces the Launch of the 2nd Annual Medicaid Rebate Summit
Summit will address the interpretation of the anticipated Final Rule and the larger implications of Medicaid expansion.
Wednesday, November 13, 2013
Scientific News
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!